Advanced search
Publication Cover
Leukemia & Lymphoma Volume 26, 1997 - Issue 3-4
Submit an article Journal homepage
192
Views
61
CrossRef citations to date
0
Altmetric
Original Article

Therapy of Patients with T-cell Lymphomas and Leukemias Using an Anti-CD7 Monoclonal Antibody-Rich a Chain Immunotoxin

Arthur E. Frankel Departments of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA
,
Joseph H. Laver Departments of Pediatrics, Medical University of South Carolina, Charleston, South Carolina, USA
,
Mark C. Willingham Departments of Pathology, Medical University of South Carolina, Charleston, South Carolina, USA
,
Linda J. Burns Departments of Medicine, University of Minnesota, Minnesota, USA
,
John H. Kersey Departments of Cancer Center, University of Minnesota, Minnesota, USA
&
Daniel A. Vallera Departments of Cancer Center, University of Minnesota, Minnesota, USA
Pages 287-298 | Published online: 01 Jul 2009

Citations (61)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Faris QB Alenzi, Richard KH Wyse & Waleed G Altamimi. (2004) Apoptosis as a tool for therapeutic agents in haematological diseases. Expert Opinion on Biological Therapy 4:3, pages 407-420.
Read now
Robert J Kreitman. (2000) Immunotoxins. Expert Opinion on Pharmacotherapy 1:6, pages 1117-1129.
Read now

Articles from other publishers (59)

Ibrahim N. Muhsen, LaQuisa C. Hill & Carlos A. Ramos. (2023) Chimeric Antigen Receptor T Cells in Hodgkin and T-Cell Lymphomas. Hematology/Oncology Clinics of North America 37:6, pages 1107-1124.
Crossref
Jile Liu, Yi Zhang, Ruiting Guo, Yifan Zhao, Rui Sun, Shujing Guo, Wenyi Lu & Mingfeng Zhao. (2023) Targeted CD7 CAR T-cells for treatment of T-Lymphocyte leukemia and lymphoma and acute myeloid leukemia: recent advances. Frontiers in Immunology 14.
Crossref
Daniele Caracciolo, Antonia Mancuso, Nicoletta Polerà, Caterina Froio, Giuseppe D’Aquino, Caterina Riillo, Pierosandro Tagliaferri & Pierfrancesco Tassone. (2023) The emerging scenario of immunotherapy for T-cell Acute Lymphoblastic Leukemia: advances, challenges and future perspectives. Experimental Hematology & Oncology 12:1.
Crossref
Pouya Safarzadeh Kozani, Abdolhossein Naseri, Seyed Mohamad Javad Mirarefin, Faeze Salem, Mojtaba Nikbakht, Sahar Evazi Bakhshi & Pooria Safarzadeh Kozani. (2022) Nanobody-based CAR-T cells for cancer immunotherapy. Biomarker Research 10:1.
Crossref
Simon K. Krebs, Marlitt Stech, Felix Jorde, Nathanaël Rakotoarinoro, Franziska Ramm, Sophie Marinoff, Sven Bahrke, Antje Danielczyk, Doreen A. Wüstenhagen & Stefan Kubick. (2022) Synthesis of an Anti-CD7 Recombinant Immunotoxin Based on PE24 in CHO and E. coli Cell-Free Systems. International Journal of Molecular Sciences 23:22, pages 13697.
Crossref
Yuewen Zhai, Yuying Ma, Bo Pang, Jinnan Zhang, Ying Li, Yalan Rui, Tian Xu, Yu Zhao, Zhiyu Qian, Yueqing Gu & Siwen Li. (2021) A cascade targeting strategy based on modified bacterial vesicles for enhancing cancer immunotherapy. Journal of Nanobiotechnology 19:1.
Crossref
Christos Georgiadis, Jane Rasaiyaah, Soragia Athina Gkazi, Roland Preece, Aniekan Etuk, Abraham Christi & Waseem Qasim. (2021) Base-edited CAR T cells for combinational therapy against T cell malignancies. Leukemia 35:12, pages 3466-3481.
Crossref
Pouya Safarzadeh Kozani, Pooria Safarzadeh Kozani & Fatemeh Rahbarizadeh. (2021) CAR-T cell therapy in T-cell malignancies: Is success a low-hanging fruit?. Stem Cell Research & Therapy 12:1.
Crossref
Jing Zhang, Arvind Jain, Sabine Milhas, Daniel J. Williamson, Justyna Mysliwy, Adam Lodge, Jenny Thirlway, Majid Al Nakeeb, Ami Miller & Terry H. Rabbitts. (2021) An antibody-drug conjugate with intracellular drug release properties showing specific cytotoxicity against CD7-positive cells. Leukemia Research 108, pages 106626.
Crossref
Arvind K. JainCarole J. R. BatailleSabine MilhasAmi MillerJing ZhangTerry H. Rabbitts. (2020) Immunopolymer Lipid Nanoparticles for Delivery of Macromolecules to Antigen-Expressing Cells. ACS Applied Bio Materials 3:12, pages 8481-8495.
Crossref
Fátima Bayón-Calderón, María L. Toribio & Sara González-García. (2020) Facts and Challenges in Immunotherapy for T-Cell Acute Lymphoblastic Leukemia. International Journal of Molecular Sciences 21:20, pages 7685.
Crossref
Juanjuan Zhao, Meirong Wu, Zhifeng Li, Sheng Su, Yin Wen, Litian Zhang & Yuhua Li. (2020) Chimeric antigen receptor therapy in hematological malignancies: antigenic targets and their clinical research progress. Annals of Hematology 99:8, pages 1681-1699.
Crossref
Heike Franke, Reinhold Scholl & Achim Aigner. (2019) Ricin and Ricinus communis in pharmacology and toxicology-from ancient use and “Papyrus Ebers” to modern perspectives and “poisonous plant of the year 2018”. Naunyn-Schmiedeberg's Archives of Pharmacology 392:10, pages 1181-1208.
Crossref
Diego Sánchez-MartínezMatteo L. BaroniFrancisco Gutierrez-AgüeraHeleia Roca-HoOscar Blanch-LombarteSara González-García, Montserrat TorrebadellJordi JuncaManuel Ramírez-Orellana, Talía Velasco-Hernández, Clara BuenoJosé Luís FusterJulia G. PradoJulien CalvoBenjamin UzanJan CoolsMireia CamosFrançoise PflumioMaría Luisa ToribioPablo Menéndez. (2019) Fratricide-resistant CD1a-specific CAR T cells for the treatment of cortical T-cell acute lymphoblastic leukemia. Blood 133:21, pages 2291-2304.
Crossref
Lauren D. Scherer, Malcolm K. Brenner & Maksim Mamonkin. (2019) Chimeric Antigen Receptors for T-Cell Malignancies. Frontiers in Oncology 9.
Crossref
Yi Tian Png, Natasha Vinanica, Takahiro Kamiya, Noriko Shimasaki, Elaine Coustan-Smith & Dario Campana. (2017) Blockade of CD7 expression in T cells for effective chimeric antigen receptor targeting of T-cell malignancies. Blood Advances 1:25, pages 2348-2360.
Crossref
Diogo Gomes-Silva, Madhuwanti SrinivasanSandhya SharmaCiaran M. Lee, Dimitrios L. WagnerTimothy H. Davis, Rayne H. RouceGang Bao, Malcolm K. BrennerMaksim Mamonkin. (2017) CD7-edited T cells expressing a CD7-specific CAR for the therapy of T-cell malignancies. Blood 130:3, pages 285-296.
Crossref
D. Hendriks, G. Choi, M. de Bruyn, V.R. Wiersma & E. Bremer. 2017. 289 383 .
Christiane Chen-Santel. 2017. Childhood Acute Lymphoblastic Leukemia. Childhood Acute Lymphoblastic Leukemia 201 237 .
Andra-Sorina Tatar, Timea Nagy-Simon, Ciprian Tomuleasa, Sanda Boca & Simion Astilean. (2016) Nanomedicine approaches in acute lymphoblastic leukemia. Journal of Controlled Release 238, pages 123-138.
Crossref
Jinle Tang, Jialu Li, Xuejun Zhu, Yuan Yu, Dan Chen, Lei Yuan, Zhenyang Gu, Xingding Zhang, Lin Qi, Zhishu Gong, Pengjun Jiang, Juhua Yu, Huimin Meng, Gangli An, Huyong Zheng & Lin Yang. (2016) Novel CD7-specific nanobody-based immunotoxins potently enhanced apoptosis of CD7-positive malignant cells. Oncotarget 7:23, pages 34070-34083.
Crossref
Katja Spiess, Mette Høy Jakobsen, Thomas N Kledal & Mette M Rosenkilde. (2016) The future of antiviral immunotoxins. Journal of Leukocyte Biology 99:6, pages 911-925.
Crossref
Douglas A. Lappi & Fiorenzo Stirpe. 2014. Ribosome-inactivating Proteins. Ribosome-inactivating Proteins 244 252 .
Alan S. Wayne. 2013. Childhood Leukemias. Childhood Leukemias 563 581 .
Kentaro Yomogida, Yuan Chou, Jonathan Pang, Bobby Baravati, Brian J. Maniaci, Shili Wu, Yong Zhu & Cong-Qiu Chu. (2012) Streptavidin suppresses T cell activation and inhibits IL-2 production and CD25 expression. Cytokine 58:3, pages 431-436.
Crossref
Nurit Becker & Itai Benhar. (2012) Antibody-Based Immunotoxins for the Treatment of Cancer. Antibodies 1:1, pages 39-69.
Crossref
Michael P. Czech, Myriam Aouadi & Gregory J. Tesz. (2011) RNAi-based therapeutic strategies for metabolic disease. Nature Reviews Endocrinology 7:8, pages 473-484.
Crossref
Arend von Stackelberg. 2011. New Agents for the Treatment of Acute Lymphoblastic Leukemia. New Agents for the Treatment of Acute Lymphoblastic Leukemia 221 271 .
Assaf Shapira & Itai Benhar. (2010) Toxin-Based Therapeutic Approaches. Toxins 2:11, pages 2519-2583.
Crossref
Roberta Traini, Gal Ben-Josef, Diana V. Pastrana, Elizabeth Moskatel, Ashima K. Sharma, Antonella Antignani & David J. FitzGerald. (2010) ABT-737 Overcomes Resistance to Immunotoxin-Mediated Apoptosis and Enhances the Delivery of Pseudomonas Exotoxin–Based Proteins to the Cell Cytosol. Molecular Cancer Therapeutics 9:7, pages 2007-2015.
Crossref
Giulio Fracasso, Fiorenzo Stirpe & Marco Colombatti. 2010. Toxic Plant Proteins. Toxic Plant Proteins 225 263 .
Arthur E. Frankel, Jung-Hee Woo & David M. Neville. 2009. Principles of Cancer Biotherapy. Principles of Cancer Biotherapy 407 449 .
Lev Osherovich. (2008) Interfering with HIV. Science-Business eXchange 1:29, pages 10-11.
Crossref
Priti Kumar, Hong-Seok Ban, Sang-Soo Kim, Haoquan Wu, Todd Pearson, Dale L. Greiner, Amale Laouar, Jiahong Yao, Viraga Haridas, Katsuyoshi Habiro, Yong-Guang Yang, Ji-Hoon Jeong, Kuen-Yong Lee, Yong-Hee Kim, Sung Wan Kim, Matthias Peipp, Georg H. Fey, N. Manjunath, Leonard D. Shultz, Sang-Kyung Lee & Premlata Shankar. (2008) T Cell-Specific siRNA Delivery Suppresses HIV-1 Infection in Humanized Mice. Cell 134:4, pages 577-586.
Crossref
Jung Hee Woo, Sarah H. Bour, Tony Dang, Yu-Jen Lee, Seong Kyu Park, Elissa Andreas, Soo Hyun Kang, Jen-Sing Liu, David M. NevilleJrJr & Arthur E. Frankel. (2008) Preclinical studies in rats and squirrel monkeys for safety evaluation of the bivalent anti-human T cell immunotoxin, A-dmDT390–bisFv(UCHT1). Cancer Immunology, Immunotherapy 57:8, pages 1225-1239.
Crossref
Jung Hee Woo, Jen-Sing Liu, Soo Hyun Kang, Ravibhushan Singh, Seong Kyu Park, Yunpeng Su, Janelle Ortiz, David M. NevilleJr.Jr., Mark C. Willingham & Arthur E. Frankel. (2008) GMP production and characterization of the bivalent anti-human T cell immunotoxin, A-dmDT390-bisFv(UCHT1) for phase I/II clinical trials. Protein Expression and Purification 58:1, pages 1-11.
Crossref
Nicola Gökbuget & Dieter Hoelzer. (2006) Novel antibody-based therapy for acute lymphoblastic leukaemia. Best Practice & Research Clinical Haematology 19:4, pages 701-713.
Crossref
Yoram Reiter & Avital Lev. 2006. Encyclopedia of Molecular Cell Biology and Molecular Medicine. Encyclopedia of Molecular Cell Biology and Molecular Medicine.
Robert J. Kreitman. (2006) Immunotoxins for targeted cancer therapy. The AAPS Journal 8:3, pages E532-E551.
Crossref
Edwin BremerBram ten CateDouwe F. SamploniusLou F. M. H. de LeijWijnand Helfrich. (2006) CD7-restricted activation of Fas-mediated apoptosis: a novel therapeutic approach for acute T-cell leukemia. Blood 107:7, pages 2863-2870.
Crossref
Edwin Bremer, Douwe F. Samplonius, Matthias Peipp, Linda van Genne, Bart-Jan Kroesen, Georg H. Fey, Martin Gramatzki, Lou F.M.H. de Leij & Wijnand Helfrich. (2005) Target Cell–Restricted Apoptosis Induction of Acute Leukemic T Cells by a Recombinant Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Fusion Protein with Specificity for Human CD7. Cancer Research 65:8, pages 3380-3388.
Crossref
Arthur E. Frankel. (2005) New anti-T cell immunotoxins for the clinic. Leukemia Research 29:3, pages 249-251.
Crossref
Claire E Dearden & Francine M Foss. (2003) Peripheral T- cell lymphomas: diagnosis and management. Hematology/Oncology Clinics of North America 17:6, pages 1351-1366.
Crossref
Faris Q. B. Alenzi & Anthony N. Warrens. (2003) Cellular and molecular themes in apoptosis. Wiener Klinische Wochenschrift 115:15-16, pages 563-574.
Crossref
Arthur E. Frankel, David M. Neville, Thomas A. Bugge, Robert J. Kreitman & Stephen H. Leppla. (2003) Immunotoxin therapy of hematologic malignancies. Seminars in Oncology 30:4, pages 545-557.
Crossref
Arthur E. Frankel, Robert J. Kreitman, Ira Pastan & John R. Murphy. 2003. Principles of Cancer Biotherapy. Principles of Cancer Biotherapy 391 433 .
Richard A. Messmann & Edward A. Sausville. 2002. Encyclopedia of Cancer. Encyclopedia of Cancer 297 306 .
M Tommasi, D Castelletti, M Pasti, G Fracasso, I Lorenzetti, S Sartoris, C Pera, G B Ferrara, G Tridente & M Colombatti. (2001) Identification of ricin A-chain HLA class II-restricted epitopes by human T-cell clones. Clinical and Experimental Immunology 125:3, pages 391-400.
Crossref
Madhu Sudhan Shaik, Narayanasamy Kanikkannan & Mandip Singh. (2001) Conjugation of anti-My9 antibody to stealth monensin liposomes and the effect of conjugated liposomes on the cytotoxicity of immunotoxin. Journal of Controlled Release 76:3, pages 285-295.
Crossref
P�l Kristian Selbo, Gowsala Sivam, �ystein Fodstad, Kirsten Sandvig & Kristian Berg. (2001) In vivo documentation of photochemical internalization, a novel approach to site specific cancer therapy. International Journal of Cancer 92:5, pages 761-766.
Crossref
Yoram Reiter. 2001. 93 124 .
Ypke V. J. M. van OosterhoutLiesbeth van EmstAnton V. M. B. SchattenbergWil J. M. TaxDirk J. RuiterHergen SpitsFokke M. NagengastRoos MasereeuwSabine EversTheo de WitteFrank W. M. B. Preijers. (2000) A combination of anti-CD3 and anti-CD7 ricin A-immunotoxins for the in vivo treatment of acute graft versus host disease. Blood 95:12, pages 3693-3701.
Crossref
Stewart D. Lyman, Sabine Escobar, Anne-Marie Rousseau, Allison Armstrong & William C. Fanslow. (2000) Identification of CD7 as a Cognate of the Human K12 (SECTM1) Protein. Journal of Biological Chemistry 275:5, pages 3431-3437.
Crossref
Ian T. W. Matthews. 2000. Diagnostic and Therapeutic Antibodies. Diagnostic and Therapeutic Antibodies 73 84 .
T.A. Waldmann. (2000) T-cell receptors for cytokines: Targets for immunotherapy of leukemia/lymphoma. Annals of Oncology 11, pages S101-S106.
Crossref
Robert J. KreitmanWyndham H. WilsonDavid RobbinsInger MarguliesMaryalice Stetler-StevensonThomas A. WaldmannIra Pastan. (1999) Responses in Refractory Hairy Cell Leukemia to a Recombinant Immunotoxin. Blood 94:10, pages 3340-3348.
Crossref
Robert J Kreitman. (1999) Immunotoxins in cancer therapy. Current Opinion in Immunology 11:5, pages 570-578.
Crossref
Charlotte E. Hotchkiss, Philip D. Hall, J.Mark Cline, Mark C. Willingham, Robert J. Kreitman, Jean Gardin, Amy Latimer, Jason Ramage, Theodore Feely, Stephen DeLatte, Edward P. Tagge & Arthur E. Frankel. (1999) Toxicology and Pharmacokinetics of DTGM, a Fusion Toxin Consisting of a Truncated Diphtheria Toxin (DT388) Linked to Human Granulocyte-Macrophage Colony-Stimulating Factor, in Cynomolgus Monkeys. Toxicology and Applied Pharmacology 158:2, pages 152-160.
Crossref
A. E. Frankel & M. C. Willingham. 1998. Clinical Applications of Immunotoxins. Clinical Applications of Immunotoxins 115 120 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.